New antibody-drug conjugate shows clinical benefit for advanced platinum-resistant ovarian cancer

Patients with advanced platinum-resistant ovarian cancer whose disease had progressed on standard therapy experienced clinical benefit when treated with the investigational antibody-drug conjugate (ADC) QLS5132, according to results of a Phase I clinical trial presented at the 2026 American Association for Cancer Research (AACR) Annual Meeting, held April 17-22. Source link

Read More

New mouse model reveals why chronic muscle inflammation resists standard drugs

An international research team with the participation of researchers from the University Medical Center Göttingen (UMG), Germany, has developed a mouse model that provides new insights into the development of a rare but serious muscle disease. The researchers were able to demonstrate that persistent inflammation in inclusion body myositis is linked to impaired cellular “garbage…

Read More

Reproductive justice framework is essential to addressing inequities in high-risk pregnancy care, argue researchers

A new commentary in Reproductive Health calls for reframing care of fetal status through a reproductive justice (RJ) lens, arguing that systemic inequities, not just medical factors, shape the options available to families. A team of researchers led by Penn Nursing and SisterSong the Women of Color Reproductive Justice Network wrote the editorial, which highlights…

Read More

This shrimp-inspired camera sees hidden cancer spread and could transform how surgeons remove lymph nodes

Researchers have developed a compact camera that captures ultraviolet, near-infrared and visible images using a single chip. Inspired by the multiwavelength vision ability of mantis shrimp, the camera could help surgeons identify tumor-associated lymph nodes and assess whether cancer has spread to them, making cancer surgery safer and less invasive. Source link

Read More